Global Oncology Academy
Popular
Christophe Le Tourneau, MD, PhD
Marc Oliva, MD, PhD
- MinuteCE®
The Case for Change: Why Perioperative Immunotherapy Matters in LA HNSCC
0.50 program creditsChristophe Le Tourneau, MD, PhD
Marc Oliva, MD, PhD
- NEW EPISODEMinuteCE®
From Abstract to Action in Breast Cancer: Interpreting Recent Data on Oral SERDs and Endocrine Targeting Strategies
0.50 program creditsAditya Bardia, MD, MPH, FASCO
Erica L. Mayer, MD, MPH
- NEW EPISODEMinuteCE®
Cracking the Code: Risk Stratification Guidelines to Identify High-Risk Patients
1.00 program creditScott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
Scott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
Alexandria May, PharmD, BCPS
Prithviraj Bose, MD
Medical News
- 07/23/2026
- 07/21/2026
- 07/20/2026
- 07/20/2026
CME/CE
- NEW EPISODEMinuteCE®
ADT Intensification in Biochemically Recurrent Prostate Cancer: When to Act
1.00 program creditScott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
Tiffany Traina, MD
Javier Cortes, MD, PhD
Javier Cortes, MD, PhD
Tiffany Traina, MD
Javier Cortes, MD, PhD
Clinical Practice
Charles Turck, PharmD, BCPS, BCCCP
Jason Starr, DO
Christophe Le Tourneau, MD, PhD
Marc Oliva, MD, PhD
Scott T. Tagawa, MD, MS
Mary-Ellen Taplin, MD
Tiffany Traina, MD
Programs
- MinuteCE®
Managing Adverse Events Associated With TROP2-Directed ADCs in Metastatic TNBC
0.75 program creditsTiffany Traina, MD
Javier Cortes, MD, PhD
Charles Turck, PharmD, BCPS, BCCCP
Bilal Siddiqui, MD